Apimeds Pharmaceuticals US (APUS) vs Curanex Pharmaceuticals (CURX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Curanex Pharmaceuticals is the larger company by market cap ($8.3 million vs $7.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | CURX |
|---|---|---|
| Share price | $5.02 | $5.31 |
| Market cap | $7.58M | $8.33M |
| 1-day change | -8.89% | +11.55% |
| YTD return | -69.39% | — |
| 1-year return | -73.01% | — |
| EPS (TTM) | $-32.83 | $-8.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $16.94 |
| 52-week low | $1.51 | $3.58 |
| Distance from 52-week high | -91.59% | -68.65% |
| Average volume | 3.67M | 20.11K |
| Shares outstanding | 1.51M | 1.57M |
| Employees | — | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
APUS vs CURX FAQ
Which is bigger, Apimeds Pharmaceuticals US or Curanex Pharmaceuticals?
Curanex Pharmaceuticals (CURX) is larger, with a market capitalization of $8.33M compared with $7.58M for Apimeds Pharmaceuticals US (APUS).
Are Apimeds Pharmaceuticals US and Curanex Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.